Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 14, 2020

SELL
$234.65 - $260.95 $41,063 - $45,666
-175 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$197.81 - $242.74 $34,616 - $42,479
175 New
175 $41,000
Q1 2020

Apr 30, 2020

SELL
$182.24 - $241.7 $71,073 - $94,263
-390 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$189.21 - $243.2 $73,791 - $94,848
390 New
390 $94,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aft, Forsyth & Sober, LLC Portfolio

Follow Aft, Forsyth & Sober, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Sober, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Sober, LLC with notifications on news.